Results 111 to 120 of about 4,667 (141)

Summary of Evidence of Effectiveness for Selective serotonin Re- Uptake Inhibitors and Tricyclic Antidepressants. [PDF]

, 2000
Beard, S.M., McGarrity, C., Touch , S.
core  

Metabolic Modulators in Depression: Emerging Molecular Mechanisms and Therapeutic Opportunities. [PDF]

Int J Mol Sci
Dyndał K, Pańczyszyn-Trzewik P, Sowa-Kućma M.   +2 more
europepmc   +1 more source

Investigating the cytotoxicity and genotoxicity of Vortioxetine with in vivo and in silico methods. [PDF]

Sci Rep
Çicekliyurt MM, İnan P, Günay M, Akkuş G, Çiçekliyurt A.   +4 more
europepmc   +1 more source

Disodium Cromoglycate Attenuates the Depressive-Like Behaviors in Mice by Inhibiting Neuroinflammation. [PDF]

CNS Neurosci Ther
Xiao Y, Liu K, Yuan Z, Liao Y.
europepmc   +1 more source

Adverse event reports of seizure for insomnia medication from 1967 to 2023. [PDF]

Sci Rep
Kim TH, Lee K, Hwang J, Lee S, Jo H, Cho H, Lee H, Baek HJ, Kang J, Nehs CJ, Fond G, Boyer L, Chung EK, Yon DK.   +13 more
europepmc   +1 more source

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Has Deep Brain Stimulation Shown Its Full Potential in Treatment-Resistant Depression? A Scoping Review. [PDF]

Biol Psychiatry Glob Open Sci
Puke L, Amoussou JR, von Gunten A, Elowe J.   +3 more
europepmc   +1 more source

Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice. [PDF]

Clin Psychopharmacol Neurosci
Serretti A.
europepmc   +1 more source

Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pipeline phase 3 medications. [PDF]

BMC Psychiatry
IsHak WW, Hirsch D, Renteria S, Totlani J, Murphy N, Chang T, Abdelsalam R, Salem M, Meyer A, Keerthana S, Liu A, Contreras L, Tadros E, Hedrick R, Danovitch I, Pechnick RN.   +15 more
europepmc   +1 more source

[Controlled long-term prevention of unipolar depression with antidepressive agents of the second generation (SSRI)].

Psychiatrische Praxis, 1997
Relapse and recurrence are common following successful short-term treatment of unipolar depression. Evidence from a number of controlled double-blind investigations indicates that a patient with a history of depressive episodes is best protected against future episodes by being maintained on the same antidepressant agent at the same dose that was used ...
openaire   +1 more source